Clinical Trials Browser

Phase 2/3 × enzalutamide × Genitourinary × Clear all

NCT02685397 2024-12-04

PCS IX

Phase 2/3 Active not recruiting

Castration-resistant Prostate Cancer Patients with Oligometastases

NCT05627752 2024-02-28

Docetaxel Alone or in Combination With Enzalutamide for mCRPC Previously Treated With Abiraterone at mHSPC Stage

Phase 2/3 Unknown

Prostatic Neoplasms

NCT00268476 2023-04-18

STAMPEDE

Phase 2/3 Active not recruiting

11,992 enrolled

Prostatic Neoplasms